Condition
Fuchs
Total Trials
5
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
P 2 (3)
P 3 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07024693Phase 2Recruiting
DT-168 in Keratoplasty Patients With Fuchs Endothelial Corneal Dystrophy
NCT05289661Phase 3Active Not RecruitingPrimary
Descemet Endothelial Thickness Comparison Trial I
NCT05275972Phase 3RecruitingPrimary
Descemet Endothelial Thickness Comparison Trial II
NCT07729137Phase 2Not Yet Recruiting
Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction
NCT04676737Phase 2Completed
TTHX1114(NM141) in Combination With DWEK/DSO
Showing all 5 trials